Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Phillips 66
PSX
$96.7B
| $6.6M | ﹤0.01% |
81,926
-34,274
| -29% | -$2.66M |
|
1902
PUT
VF Corp
VFC
$5.46B
| $6.6M | ﹤0.01% |
124,997
-20,072
| -14% | -$1.16M |
|
1903
Norwegian Cruise Line
NCLH
$7.85B
| $6.6M | ﹤0.01% |
174,953
+47,533
| +37% | +$1.84M |
|
1904
PUT
Vulcan Materials
VMC
$35.5B
| $6.6M | ﹤0.01% |
58,000
-15,000
| -21% | -$1.77M |
|
|
JO
1905
CALL
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
| $6.59M | ﹤0.01% |
296,200
-54,700
| -16% | -$1.19M |
|
|
FMI
1906
PUT
DELISTED
Foundation Medicine, Inc.
FMI
| $6.59M | ﹤0.01% |
282,100
+111,300
| +65% | +$2.53M |
|
|
CST
1907
CALL
DELISTED
CST Brands, Inc.
CST
| $6.58M | ﹤0.01% |
136,900
-245,000
| -64% | -$11.3M |
|
1908
PUT
Amdocs
DOX
$6.5B
| $6.58M | ﹤0.01% |
113,700
+97,900
| +620% | +$5.77M |
|
|
ICPT
1909
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $6.58M | ﹤0.01% |
39,962
-89,562
| -69% | -$14.1M |
|
1910
Invesco CurrencyShares Euro Currency Trust
FXE
$360M
| $6.56M | ﹤0.01% |
60,024
-15,879
| -21% | -$1.73M |
|
1911
PUT
Ecolab
ECL
$81.5B
| $6.56M | ﹤0.01% |
53,900
+49,800
| +1,215% | +$6.01M |
|
|
RICE
1912
DELISTED
Rice Energy Inc.
RICE
| $6.56M | ﹤0.01% |
+251,095
| New | +$6.23M |
|
1913
CALL
Westlake Corp
WLK
$9.53B
| $6.55M | ﹤0.01% |
122,400
+41,100
| +51% | +$1.98M |
|
|
AUY
1914
DELISTED
Yamana Gold, Inc.
AUY
| $6.55M | ﹤0.01% |
1,519,238
+94,619
| +7% | +$487K |
|
|
COHR
1915
PUT
DELISTED
Coherent Inc
COHR
| $6.54M | ﹤0.01% |
59,200
+15,800
| +36% | +$1.64M |
|
1916
CALL
Southern Copper
SCCO
$180B
| $6.54M | ﹤0.01% |
271,495
-52,945
| -16% | -$1.26M |
|
1917
iShares MSCI Singapore ETF
EWS
$1.24B
| $6.53M | ﹤0.01% |
300,439
+281,657
| +1,500% | +$6.12M |
|
1918
PUT
Huntington Ingalls Industries
HII
$11.7B
| $6.52M | ﹤0.01% |
42,500
-10,700
| -20% | -$1.78M |
|
|
AERI
1919
DELISTED
Aerie Pharmaceuticals
AERI
| $6.51M | ﹤0.01% |
+172,585
| New | +$3.81M |
|
1920
Idexx Laboratories
IDXX
$43.6B
| $6.51M | ﹤0.01% |
57,769
+38,175
| +195% | +$4.02M |
|
1921
CALL
Cheniere Energy
CQP
$33.2B
| $6.51M | ﹤0.01% |
222,500
+100
| +0% | +$2.78K |
|
1922
PUT
Franklin Covey
FC
$227M
| $6.51M | ﹤0.01% |
+365,300
| New | +$5.89M |
|
1923
PUT
Shopify
SHOP
$193B
| $6.5M | ﹤0.01% |
1,515,000
-375,000
| -20% | -$1.43M |
|
|
CEQP
1924
PUT
DELISTED
Crestwood Equity Partners LP
CEQP
| $6.49M | ﹤0.01% |
305,500
-94,300
| -24% | -$1.97M |
|
|
XEC
1925
PUT
DELISTED
CIMAREX ENERGY CO
XEC
| $6.49M | ﹤0.01% |
48,300
+5,100
| +12% | +$640K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.